Coenzyme Q10 and Metabolic Syndrome

Metabolic syndrome, also known as syndrome X, is the name for a cluster of conditions – high blood pressure, high blood sugar, insulin resistance, increased risk of blood clots, abnormal cholesterol – that are dangerous themselves and can lead to heart disease and type 2 diabetes.  Coenzyme Q10 supplementation can improve the associated mitochondrial dysfunction and reduce oxidative stress.

Coenzyme Q10, the essential bio-nutrient, has properties that are germane to the treatment of several of the risk factors associated with the umbrella term “metabolic syndrome” [Casagrande].

These properties include the following:

  • a bio-energetics role in the cellular production of ATP energy [Casagrande]
  • a role as a fat-soluble antioxidant protecting against oxidative damage by harmful free radicals to cells and lipids [Casagrande]
  • an anti-inflammatory effect [Zhai]
  • a role in the protection and improvement of endothelial function [Gao]

What Factors Reduce Plasma Coenzyme Q10 Levels?

Typically, we expect to find plasma Coenzyme Q10 concentrations ranging from 0.6 to 1.0 micrograms per milliliter in unsupplemented healthy individuals.  With daily supplementation, it is possible to raise the plasma Coenzyme Q10 levels above the 2.5 micrograms per milliliter level needed for a therapeutic effect in heart disease and above the 3.5 micrograms per milliliter level needed for a therapeutic effect in neurodegenerative disease [Langsjoen].

read more

WholeFoods Magazine Interview about Coenzyme Q10

Dr. Richard Passwater’s interviews with Dr. William Judy (pictured here) in the WholeFoods Magazine are fascinating reading about the absorption and clinical effects of Coenzyme Q10.

In the February and March 2019 issues of WholeFoods Magazine, Dr. Richard Passwater has published part 1 and part 2 of his interview with Dr. William Judy. These interviews are must reading [Passwater 2019].

The Main Coenzyme Q10 Points in the Dr. Passwater – Dr. Judy Interviews

Dr. Passwater’s interviews with Dr. Judy focus on current issues in CoQ10 research. These issues are of interest to all of us who want to maintain good heart health.

Coenzyme Q10 Molecules are Redox Molecules With Oxidized and Reduced Forms

Coenzyme Q10 molecules are redox molecules with an oxidized form of Coenzyme Q10 called ubiquinone, an intermediate partially reduced form called ubisemiquinone, and a reduced form called ubiquinol. The ubiquinone and ubiquinol forms are both used in Coenzyme Q10 supplements. Both forms are active and important forms.

read more

Coenzyme Q10: An Insider’s Guide by Dr. William V. Judy

Dr. William V. Judy, the founder and president of the SIBR Research Institute, was one of the first researchers to raise questions about misleading marketing claims for Coenzyme Q10 products. Now he has written a book to share his knowledge of the relevant clinical research into the absorption, bio-availability, efficacy, and safety of CoQ10 supplements.

Coenzyme Q10 is, literally, the substance that powers life.  It is an essential bio-nutrient required for the cellular process of ATP energy production.  It is also an important fat-soluble antioxidant.  Oral CoQ10 supplementation is positively associated with the reduction of blood bio-markers for oxidative stress and inflammation.

Now available from amazon.com is Dr. William Judy’s new book entitled Coenzyme Q10: An Insider’s Guide. 

A simple search for the words Judy and Q10 will find the book on Amazon.

read more

Coenzyme Q10 Supplements for Patients with Type 2 Diabetes

Diabetes is a major health problem world-wide. More than 90% of patients with diabetes have type 2 diabetes in which case the pancreas does not make enough insulin or the insulin that the pancreas makes is not effective. Patients with type 2 diabetes are at higher risk of developing heart disease, hypertension, and stroke. Oxidative stress is a known factor in the development and progression of type 2 diabetes. Coenzyme Q10 is an important fat-soluble antioxidant that can scavenge harmful free radicals and protect the cells from oxidative damage.

Individuals with type 2 diabetes are known to have considerably lower plasma/serum Coenzyme Q10 concentrations than do individuals who do not have diabetes [Zhang].

A 2018 meta-analysis and systematic review of the research literature indicates that Coenzyme Q10 supplementation improves glycemic control and increases HDL-cholesterol in individuals with type 2 diabetes [Zhang].

CoQ10 Supplementation and Glycemic Control

The results of the meta-analysis, drawn from an aggregated 13 clinical trials enrolling 795 patients with type 2 diabetes, show that the CoQ10 supplementation significantly decreased HbA1c (p=0.03) and fasting glucose (p=0.005).

read more

Coenzyme Q10 and Male Infertility

Data from randomized controlled trials show that Coenzyme Q10 supplementation is positively associated with improved sperm density and motility and, to a certain extent, with improved pregnancy rates.

Coenzyme Q10 supplementation results in significant improvement in various sperm parameters: sperm density, sperm motility, and sperm morphology and, quite possibly, in pregnancy rates [Safarinejad].

Actually, we have known about the benefits of Coenzyme Q10 for treating men with significant abnormalities in sperm morphology and motility for 10 – 15 years now.  Let’s have a look at the clinical research results reported in journal articles indexed by Medline.

CoQ10 and Male Infertility Associated with Abnormal Sperm Parameters

Safarinejad, M. R. (2009). Efficacy of Coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. The Journal Of Urology, 182(1), 237–248.

Researchers enrolled 212 infertile men with various sperm abnormalities. Half of the patients were randomly assigned to receive 300 milligrams of Coenzyme Q10 daily, and half took matching placebos for 26 weeks.  The researchers then continued to follow the patients’ progress for a 30-week treatment-free phase.

read more

Coenzyme Q10 supplementation and coronary artery disease

Elevated total cholesterol levels and/or elevated low-density lipoprotein (LDL) cholesterol levels are associated with increased risk of coronary artery disease, which is the most common form of heart disease. Now, a meta-analysis shows that CoQ10 supplementation significantly improves total cholesterol and HDL-cholesterol in coronary artery disease patients.

Coenzyme Q10 adjuvant treatment of heart failure patients significantly improves the symptoms and survival of chronic heart failure patients [Mortensen; Morisco; Munkholm].

How does it look with Coenzyme Q10 supplementation and coronary artery disease?

Coronary artery disease is caused by hardening and narrowing of the coronary arteries that bring blood to the heart muscle? Coronary artery disease is also known as ischemic heart disease, which is heart disease characterized by reduced flow of blood containing oxygen to the heart muscle.

read more

Coenzyme Q10 adjuvant therapy for chronic heart failure

Dr. Svend Aage Mortensen (right), pictured here with Dr. Karl Folkers, was the lead researcher on the Q-Symbio study of the effects of Coenzyme Q10 adjuvant therapy for chronic heart failure patients. Now, Dr. Anne Louise Mortensen has focused in on the European patients in the international Q-Symbio study.

There are positive outcomes from an analysis of the European sub-group of chronic heart failure patients (n = 231 out of a total of 420 patients) in the international multi-center Q-Symbio study.  Two years of adjuvant treatment with 3 times 100 milligrams of ubiquinone Coenzyme Q10 daily in addition to conventional heart failure treatment reveals [Mortensen 2019]:

  • significantly fewer patients suffering major adverse cardiovascular events (= death due to heart attack or heart failure or hospitalization due to acute heart failure or pulmonary embolism) compared to placebo
  • significantly fewer heart disease deaths and all-cause deaths compared to placebo
  • significantly more improvements of the patients’ NYHA classifications compared to placebo
  • significantly improved ejection fraction compared to placebo

What was the Q-Symbio study of CoQ10 and heart failure?

The Q-Symbio study was an international multi-center randomized, double-blind, placebo-controlled study that demonstrated that daily treatment with 3 times 100 milligrams of a pharmaceutical-grade ubiquinone Coenzyme Q10 preparation for two years in addition to conventional treatment significantly improved the symptoms and survival of chronic heart failure patients [Mortensen 2014].

read more

Coenzyme Q10 and selenium supplementation for senior citizens

One of Sweden’s leading cardiologists, Professor Urban Alehagen, Department of Cardiology, Linkoping University Hospital, led the KiSel-10 research team. Dr. Alehagen conceived the idea of combining the essential trace element selenium and the vitamin-like substance Coenzyme Q10 to improve the heart health of senior citizens.  In so doing, he and his team of  researchers reduced the cardiovascular mortality of live-at-home senior citizens by over 50 per cent and improved heart function.

Let’s take a close look at the KiSel-10 clinical trial of the effect of combined selenium and Coenzyme Q10 supplementation on the heart health of senior citizens.

Who? Senior citizens.

Senior citizens … aged 70 – 88 years … average age 78 years … still living at home … generally in good health … in a clinical trial conducted by Dr. Urban Alehagen and a team of researchers from Linköping University, Linköping, Sweden …

What? Combined selenium and Coenzyme Q10 supplementation.

The KiSel-10 study enrolling 443 study participants in a four-year randomized, double-blind, placebo-controlled trial … the study name KiSel-10 is derived from the name of the municipality Kinda, the trace element selenium, and the Coenzyme Q10 … the Coenzyme Q10 used in the KiSel-10 study is the same pharmaceutical-grade Coenzyme Q10 preparation that was used in the Q-Symbio study of adjuvant treatment of chronic heart failure patients with 300 milligrams of Coenzyme Q10 (3 times 100 milligrams daily) … the Coenzyme Q10 used in both the KiSel-10 study and the Q-Symbio study was the ubiquinone form, the most tested and documented form and the most stable form …

read more

Coenzyme Q10 for fibromyalgia patients

Fibromyalgia is a serious complaint that affects women more frequently than men and occurs more frequently if there is a family history of the complaint. Fibromyalgia patients and chronic fatigue syndrome patients have similar symptoms: pain is perhaps the more common symptom for fibromyalgia patients while fatigue is often the predominant symptom in chronic fatigue syndrome. In both groups, there is a high probability of Coenzyme Q10 deficiency and a high probability that CoQ10 supplementation will alleviate symptoms.

Fibromyalgia is a chronic pain syndrome affecting an estimated 5% of people worldwide.  It is characterized by the following symptoms:

  • cognitive complaints related to concentration and memory
  • fatigue and a feeling of being tired much of the time
  • mood issues including anxiety and depression
  • muscle stiffness and soreness
  • sleep disorders

What it is that triggers fibromyalgia is not known with certainty and can vary from individual to individual.  Researchers hypothesize that fibromyalgia affects the ways in which the brain processes pain signals [Mayo Clinic].

Low Coenzyme Q10 associated with fibromyalgia

If we round up the usual suspects in our investigation of fibromyalgia, we end up making a connection between Coenzyme Q10 deficiency and fibromyalgia.

read more

How Coenzyme Q10 supplements protect us

Dr. William V. Judy, Founder and President of SIBR Research, has done basic and clinical research into the safety, absorption, and health effects of Coenzyme Q10 supplementation for 40 years. His research has documented significant health benefits of CoQ10 supplements in patients with heart failure, chronic fatigue syndrome, and heart surgery.

As we get older, the risk of heart disease increases.  There are two basic explanations for this increasing risk:

  • Mitochondrial dysfunction
  • Oxidative stress

Mitochondrial dysfunction

The mitochondria are the tiny “powerhouses” in our cells.  They are organelles with their own DNA.  They produce almost all the energy that our cells need to live and work.

A slow degeneration of the quality of the mitochondria seems to be a cause of ageing and a cause of many of the degenerative diseases that come with ageing [Know 2018].

It is in the mitochondria that the food we eat is processed together with the oxygen we breath to make cellular energy, ATP energy.

read more